Loading…

Autologous HER2 CMV bispecific CAR T cells are safe and demonstrate clinical benefit for glioblastoma in a Phase I trial

Saved in:

Bibliographic Details
Published in:	Journal for immunotherapy of cancer 2015-11, Vol.3 (Suppl 2), p.O11-O11, Article O11
Main Authors:	Ahmed, Nabil, Brawley, Vita, Hegde, Meenakshi, Bielamowicz, Kevin, Wakefield, Amanda, Ghazi, Alexia, Ashoori, Aidin, Diouf, Oumar, Gerken, Claudia, Landi, Daniel, Kalra, Mamta, Yi, Zhongzhen, Rooney, Cliona, Dotti, Gianpietro, Gee, Adrian, Heslop, Helen, Gottschalk, Stephen, Powell, Suzanne, Grossman, Robert, Wels, Winfried, Kew, Yzonne, Baskin, David, Zhang, Jonathan, New, Pamela, Hicks, John
Format:	Article
Language:	English
Subjects:	Brain cancer Care and treatment Cell receptors Development and progression Genetic aspects Glioblastoma multiforme Health aspects Lymphocytes Methods Oral Presentation Patient outcomes T cells
Citations:	Items that cite this one
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!